Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC50317 γ-AA peptide P6 (Cyclic γ-AA Peptide 6) Featured
γ-AA peptide P6 (Cyclic γ-AA P6) is a potent activator of E6 associated protein (E6AP). γ-AA peptide P6 can stimulate the self-ubiquitination of E6AP and E6AP-catalyzed substrate ubiquitination in reconstituted reactions in vitro. γ-AA peptide P6 can also enhance the ubiquitination of E6AP substrates in the cell and accelerate their degradation by the proteasome.
More description
DCC1108 Bpn-14136 Featured
Novel RBP4 antagonist with good in vitro potency and selectivity and optimal rodent pharmacokinetic (PK) and pharmacodynamic (PD) characteristics
More description
DC21463 CI-976 Featured
CI-976 (PD 128042) is a potent, selective, orally bioavailable inhibitor of ACAT-1 (Acetyl-CoA acetyltransferase 1) with IC50 of 73 nM.
More description
DC42731 FTY720(8)-Phosphate Featured
A sphingosine 1-phosphate (S1PR) receptor agonist
More description
DC11639 Shield-1 Featured
Shield-1 is a cell-permeable FKBP ligand that is designed to protect an otherwise unstable protein domain from degradation; binds tightly to FKBP, induces rapid and processive degradation of the LID domain.
More description
DCC3720 Nrf2-activator Featured
Nrf2-Activator is a potent Nrf-2 activator.
More description
DC43088 GSK'843 Featured
Selective RIP3 kinase inhibitor
More description
DC12585 TB47 Featured
QcrB inhibitor TB47 (TB47) is a novel antimycobacterial agent that fuctions as a putative respiratory complex III (QcrB) inhibitor with MIC of 0.016-0.5 ug/mL against a panel of 56 M. tuberculosis clinical isolates.
More description
DC47470 SBP-3264 Featured
SBP-3264 is a valuable chemical probe for understanding the roles of STK3 and STK4 in acute myeloid leukemia (AML).
More description
DC34482 Dihydroresveratrol Featured
Dihydroresveratrol is an SIRT1 activator. It is a primary metabolite of resveratrol.
More description
DC43788 10-Hydroxycanthin-6-one Featured
10-Hydroxycanthin-6-one is an antileukemic canthin-6-one alkaloid from Brucea antidysenterica. Antitumor agent.
More description
DC42984 9-Hydroxycanthin-6-one Featured
9-Hydroxycanthin-6-one is an alkaloid compound. 9,10-Dimethoxycanthin-6-one exhibits NF-κB inhibitory effects with an IC50 of 3.8 μM.
More description
DC28295 9-Methoxycanthin-6-one Featured
9-Methoxycanthin-6-one, a canthin-6-one alkaloid, is present in intact plant parts and in callus tissues of different explants. 9-Methoxycanthin-6-one shows anti-tumor activity.
More description
DC43524 Canthin-6-one Featured
Canthin-6-one displays a wide range of biological activities, such as antimycobacterial activity.
More description
DC72076 AZD5462 Featured
AZD5462 is a selective oral allosteric relaxin family peptide receptor 1 (RXFP1) agonist with pEC50 of 7.8. AZD5462 has better kinetic solubility and shows much improved metabolic stability compared to AZ7976 in vitro.
More description
DCB-029 Anemoside B4 Featured
Pulchinenoside B4 is a triterpenoid glycoside that inhibits cisplatin-induced apoptosis, increases in reactive oxygen species (ROS) production, and decreases in superoxide dismutase (SOD) and catalase activities. Pulchinenoside B4 also prevents increases in plasma blood urea nitrogen (BUN) and creatinine levels -- markers of kidney injury.
More description
DC21056 GMI-1271 Featured
A novel specific glycomimetic E-Selectin antagonist with Kd of 0.46 uM, IC50 of 1.75 uM.
More description
DC45418 Lipase Substrate Featured
Lipase Substrate is a substrate of lipase to detect activity.
More description
DC74615 BC-05
BC-05 is an orally active and potent inhibitor of CD13 and proteasome. BC-05 has an IC50 value of 0.13 μM for human CD13 and an IC50 value of 1.39 μM for the 20S proteasome. BC-05 can be used in multiple myeloma research.
More description
DC74614 Ucasareotide dasaroxetan
Ucasareotide dasaroxetan (SarTATE) is diagnostic agent with antineoplastic effect.
More description
DC74613 Tegomil fumarate
Tegomil fumarate is an immunomodulator.
More description
DC74611 Civorebrutinib
Civorebrutinib (WS-413) is a Bruton's tyrosine kinase inhibitor with antineoplastic effect.
More description
DC74610 XY-52
XY-52 (Compound 32) is a Stimulation-2 (ST2) inhibitor, with an IC50 value of 5.68 μM in AlphaLISA assay, and 4.59 μM in HEK-Blue assay. XY-52 increases proinflammatory T-cell proliferation. XY-52 reduces the plasma sST2 and IFNγ biomarkers in the graft versus host disease (GVHD) mice model.
More description
DC74609 9-Deazaguanine
9-Deazaguanine is a nucleoside analog with potent inhibitory activity against purine nucleoside phosphorylase (PNP).
More description
DC74607 Sucantomotide
Sucantomotide is an immunological agent for active immunization (antineoplastic).
More description
DC74606 Enavermotide
Enavermotide (UCP2) is an immunological agent for active immunization (antineoplastic).
More description
DC74602 Potassium clavulanate cellulose
Potassium clavulanate cellulose (Potassium clavulanate:cellulose (1:1)) is a mixture of potassium clavulanate and cellulose, is a bacterial β-lactamase inhibitor. Potassium clavulanate with the combination of amoxicillin can be used for the research of different infections caused by bacteria, such as sinusitis, pneumonia, ear infections, bronchitis, urinary tract infections, and infections of the skin.
More description
DC74601 Solutol HS-15
Solutol HS-15(Polyethylene glycol 12-hydroxystearate) is a Macrogol 15 hydroxy stearate, which improves permeability by disrupting the membrane structure/fluidity change.
More description
DC74599 Ethotoin
Ethotoin (Peganone) is a hydantoin derivative and an orally active anticonvulsant agent. It also exerts an antiepileptic effect and can be used in epilepsy research.
More description
DC74597 3,3-Dimethyl-1-butanol
3,3-Dimethyl-1-butanol (Neohexanol) is an orally active inhibitor of trimethylamine (TMA) and trimethylamine N-oxide (TMAO). 3,3-dimethyl-1-butanol negatively inhibits the signalling pathways of p65 NF-κB and  TGF-β1/Smad3. 3,3-dimethyl-1-butanol has potential applications in cardiovascular disease (CVD).
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X